AL-MAIDAN CLINIC FOR ORAL HEALTH SERVICES CO.

Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C)

MIDANStocksBoursa KuwaitHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q4 2026Mar 31, 2026	Q3 2026Dec 31, 2025	Q2 2026Sep 30, 2025	Q1 2026Jun 30, 2025
Market & Price
Market Capitalization	208.37M	168.08M	165.85M	155.72M	147.83M
Market Cap Growth	+51.5%	+4.1%	+2.8%	-3.4%	+1.1%
Enterprise Value	162.70M	119.10M	114.18M	107.63M	96.28M
Last Close Price	1.03	0.83	0.82	0.77	0.72
Valuation Multiples
PE Ratio	21.90	17.66	25.02	22.82	17.64
PS Ratio	3.30	2.66	2.61	2.46	2.18
PB Ratio	2.33	1.88	1.85	1.75	1.64
P/TBV Ratio	2.33	1.88	1.86	1.76	1.65
P/FCF Ratio	36.56	29.49	—	18.54	20.36
P/OCF Ratio	17.69	14.27	14.39	16.81	17.36
EV/Sales Ratio	2.58	1.89	1.80	1.70	1.42
EV/EBITDA Ratio	15.58	13.30	19.91	15.73	13.77
EV/EBIT Ratio	21.77	18.08	33.70	23.83	20.54
EV/FCF Ratio	28.55	20.90	—	12.82	13.26
Leverage & Capital
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.06
Debt / EBITDA Ratio	0.17	0.19	0.15	0.10	0.52
Debt / FCF Ratio	0.28	0.28	—	0.14	0.80
Net Debt / Equity Ratio	-0.51	-0.51	-0.55	-0.58	-0.54
Net Debt / EBITDA Ratio	-5.02	-5.11	-8.56	-7.57	-6.90
Net Debt / FCF Ratio	-8.03	-8.03	-9.32	-6.17	-6.64
Efficiency & Liquidity
Asset Turnover	0.46	0.51	0.48	0.49	0.48
Inventory Turnover	15.58	16.87	15.77	15.29	16.52
Quick Ratio	2.51	2.51	2.36	2.48	2.17
Current Ratio	2.62	2.62	2.44	2.56	2.24
Returns & Yields
Return on Equity (ROE)	+6.5%	+8.4%	+13.8%	+13.9%	-6.6%
Return on Assets (ROA)	+2.7%	+1.8%	+4.2%	+3.9%	-3.6%
Return on Invested Capital (ROIC)	+3.3%	+2.3%	+5.6%	+5.2%	-5.0%
Return on Capital Employed (ROCE)	+7.2%	+7.0%	+3.6%	+4.9%	+5.0%
Earnings Yield	+4.6%	+5.7%	+4.0%	+4.4%	+5.7%
FCF Yield	+2.7%	+3.4%	+3.2%	+5.4%	+4.9%
Dividend Yield	+2.1%	+2.4%	—	—	—
Payout Ratio	+31.9%	—	—	+98.4%	+0.1%
Buyback Yield / Dilution	—	0.0%	0.0%	—	—
Total Shareholder Return	+2.0%	+2.4%	0.0%	—	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q4 2026Mar 31, 2026	Q3 2026Dec 31, 2025	Q2 2026Sep 30, 2025	Q1 2026Jun 30, 2025
Market & Price
Market Capitalization	208.37M	168.08M	165.85M	155.72M	147.83M
Market Cap Growth	+51.5%	+4.1%	+2.8%	-3.4%	+1.1%
Enterprise Value	162.70M	119.10M	114.18M	107.63M	96.28M
Last Close Price	1.03	0.83	0.82	0.77	0.72
Valuation Multiples
PE Ratio	21.90	17.66	25.02	22.82	17.64
PS Ratio	3.30	2.66	2.61	2.46	2.18
PB Ratio	2.33	1.88	1.85	1.75	1.64
P/TBV Ratio	2.33	1.88	1.86	1.76	1.65
P/FCF Ratio	36.56	29.49	—	18.54	20.36
P/OCF Ratio	17.69	14.27	14.39	16.81	17.36
EV/Sales Ratio	2.58	1.89	1.80	1.70	1.42
EV/EBITDA Ratio	15.58	13.30	19.91	15.73	13.77
EV/EBIT Ratio	21.77	18.08	33.70	23.83	20.54
EV/FCF Ratio	28.55	20.90	—	12.82	13.26
Leverage & Capital
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.06
Debt / EBITDA Ratio	0.17	0.19	0.15	0.10	0.52
Debt / FCF Ratio	0.28	0.28	—	0.14	0.80
Net Debt / Equity Ratio	-0.51	-0.51	-0.55	-0.58	-0.54
Net Debt / EBITDA Ratio	-5.02	-5.11	-8.56	-7.57	-6.90
Net Debt / FCF Ratio	-8.03	-8.03	-9.32	-6.17	-6.64
Efficiency & Liquidity
Asset Turnover	0.46	0.51	0.48	0.49	0.48
Inventory Turnover	15.58	16.87	15.77	15.29	16.52
Quick Ratio	2.51	2.51	2.36	2.48	2.17
Current Ratio	2.62	2.62	2.44	2.56	2.24
Returns & Yields
Return on Equity (ROE)	+6.5%	+8.4%	+13.8%	+13.9%	-6.6%
Return on Assets (ROA)	+2.7%	+1.8%	+4.2%	+3.9%	-3.6%
Return on Invested Capital (ROIC)	+3.3%	+2.3%	+5.6%	+5.2%	-5.0%
Return on Capital Employed (ROCE)	+7.2%	+7.0%	+3.6%	+4.9%	+5.0%
Earnings Yield	+4.6%	+5.7%	+4.0%	+4.4%	+5.7%
FCF Yield	+2.7%	+3.4%	+3.2%	+5.4%	+4.9%
Dividend Yield	+2.1%	+2.4%	—	—	—
Payout Ratio	+31.9%	—	—	+98.4%	+0.1%
Buyback Yield / Dilution	—	0.0%	0.0%	—	—
Total Shareholder Return	+2.0%	+2.4%	0.0%	—	—